Vivosang Inc


Vivosang Inc is an investigational stage biotechnology company focused on developing pegylated human hemoglobin products to enhance oxygen delivery in medical applications, particularly in traumatic hemorrhagic injuries. Their lead product, VS-101, aims to provide targeted oxygen delivery to tissues in need, addressing significant medical needs in emergency and surgical settings.

Vivosang

Vivosang Inc

40 E Wildflower Dr, Santa Fe, NM 87506


What We Do

VS-101

An investigational biopharmaceutical product designed to provide targeted oxygen delivery in capillaries and enhance perfusion of oxygen-deprived tissues. It is based on unmodified human hemoglobin tetramers extracted from outdated human red blood cells, conjugated with polyethylene glycol (PEG) to improve oxygen-carrying capacity and delivery.


Routes of Administration


Key People

William Schindler JD

President, CEO

Kim Vandegriff PhD

Chief Science Officer

Ashok Malavalli MS

Chief of Operations


News & Updates

2023 Military Health Systems Research Symposium

Presentation on 'Novel PEGylated HBOC Bridges Circulatory Function and Oxygen Delivery in Rat Exchange Transfusion.'